TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2498550

Group type: EXPERIMENTAL
Intervention: Short term perioperative antibiotic (Group III)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Conventional postoperative antibiotic regimens (Group I and II)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Combination of penicillin and streptomycin (Group II)
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Cephamendole used perioperatively (Group III)
Number of subjects: 404
Study: 982011

Group type: EXPERIMENTAL
Intervention: Mitral valve prolapse patients
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group (17 patients without MVP)
Number of subjects: 17
Study: 30660196

Group type: EXPERIMENTAL
Intervention: Yerba mate (YM) 1000 mL/day
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Green tea (GT) 1000 mL/day
Number of subjects: 142

Group type: COMPARATOR
Intervention: Apple tea (AT, control group) 1000 mL/day
Number of subjects: 142
Study: 28318997

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy (CEA) plus medical therapy
Number of subjects: 3120

Group type: COMPARATOR
Intervention: Medical therapy alone
Number of subjects: 3120

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure at randomisation
Number of subjects: 3120

Group type: EXPERIMENTAL
Intervention: Diastolic hypertension (> 90 mmHg)
Number of subjects: 3120
Study: 25393036

Group type: EXPERIMENTAL
Intervention: Phacoemulsification (Phaco)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Combined phacoemulsification and viscogonioplasty (Phaco‐VGP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Phacoemulsification (Phaco) and Combined phacoemulsification and viscogonioplasty (Phaco‐VGP)
Number of subjects: 82
Study: 23397315

Group type: EXPERIMENTAL
Intervention: Intrathecal morphine (0.2 mg)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Periarticular multimodal drug injection
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 57
Study: 21999886

Group type: EXPERIMENTAL
Intervention: Orodispersible escitalopram (2 × 10 mg and 1 × 20 mg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Conventional escitalopram (2 × 10 mg)
Number of subjects: 29
Study: 18269385

Group type: EXPERIMENTAL
Intervention: Knee arthroscopy
Number of subjects: 100
Study: 17176206

Group type: EXPERIMENTAL
Intervention: Family treatments combined with pharmacotherapy
Number of subjects: 62
Study: 14531590

Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer (FujI II LC)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Resin composite (Z 250/Single Bond)
Number of subjects: 37
Study: 10744204

Group type: EXPERIMENTAL
Intervention: Fluorometholone 0.1% acetate
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluorometholone 0.2%
Number of subjects: 60
Study: 8617070

Group type: EXPERIMENTAL
Intervention: Lower-intensity treatment (early mobilization and sustained maximal inflations)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Higher-intensity treatment (early mobilization, sustained maximal inflations, and single-handed percussions)
Number of subjects: 78
Study: 1399734

Group type: EXPERIMENTAL
Intervention: Conformal techniques (CG)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Non-conformal techniques (NCG)
Number of subjects: 46
Study: 4078729

Group type: EXPERIMENTAL
Intervention: 96 mg of cocaine (intranasal pretreatment)
Number of subjects: 8

Group type: COMPARATOR
Intervention: 4 mg of cocaine (intranasal pretreatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cocaine (i.v. injection after intranasal pretreatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Repeated administration of cocaine
Number of subjects: 8
Study: 31050950

Group type: EXPERIMENTAL
Intervention: Home PBM treatments (n=4), administered three times per week for 12 weeks using the Vielight Neuro Gamma device.
Number of subjects: 8

Group type: COMPARATOR
Intervention: Usual care (UC, n=4) for 12 weeks.
Number of subjects: 8
Study: 30587368

Group type: EXPERIMENTAL
Intervention: Anti-MAdCAM antibody (PF-00547659)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 27543885

Group type: EXPERIMENTAL
Intervention: Loving-kindness training
Number of subjects: 122

Group type: COMPARATOR
Intervention: Mindfulness training
Number of subjects: 122
Study: 24103740

Group type: EXPERIMENTAL
Intervention: Psychological factors (Perceived Stress Scale, Profile of Mood State)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Psychological factors (depression, anger, fatigue)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Self-rated current health and HIV status
Number of subjects: 99
Study: 22913890

Group type: EXPERIMENTAL
Intervention: Colesevelam 3.75 g/day
Number of subjects: 153

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study: 20160213

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 65

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 65
Study: 17654442

Group type: EXPERIMENTAL
Intervention: Statins
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fibrates
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme (ACE) inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish oils
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antioxidants
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Folate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PKC-inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PPAR-alpha and -gamma agonists
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phosphodiesterase (PDE-5) inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statins plus ACE inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statins plus fibrates
Number of subjects: 0
Study: 15206277

Group type: EXPERIMENTAL
Intervention: Intraoperative autoblood reservation (7-8 ml/kg)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Control group (no intraoperative autoblood reservation)
Number of subjects: 109
Study: 11529211

Group type: EXPERIMENTAL
Intervention: Elevated jugular venous pressure
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: Third heart sound
Number of subjects: 2479

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2479

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 2479
Study: 9672338

Group type: EXPERIMENTAL
Intervention: RBC 400 mg b.i.d. plus clarithromycin 500 mg b.i.d. (RBC-CLA)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: RBC 400 mg b.i.d. plus tetracycline 500 mg q.i.d. plus metronidazole 500 mg t.i.d. (RBC-TET-MET)
Number of subjects: 168

Group type: EXPERIMENTAL
Intervention: RBC 400 mg b.i.d. plus amoxycillin 1000 mg b.i.d. plus clarithromycin 500 mg b.i.d. (RBC-AMO-CLA)
Number of subjects: 168

Group type: COMPARATOR
Intervention: 14-day RBC 400 mg b.i.d. plus clarithromycin 500 mg b.i.d. (RBC-CLA)
Number of subjects: 168
Study: 7943693

Group type: EXPERIMENTAL
Intervention: Second dose of mivacurium after complete recovery from > 95% neuromuscular block
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Second dose of mivacurium after 100 s exclusion from peak effect
Number of subjects: 0
Study: 2638184

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer dentifrice
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 91
Study: 4265057

Group type: EXPERIMENTAL
Intervention: Ampicillin
Number of subjects: 933
Study: 31206749

Group type: EXPERIMENTAL
Intervention: Crestal implant placement (Group-A)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Connective tissue graft (CTG) over the implant neck (Group-B)
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Thin mucosa grafted Subgroups (Group-AI/Group-BI)
Number of subjects: 46
Study: 29507283

Group type: EXPERIMENTAL
Intervention: Modafinil
Number of subjects: 27
Study: 27263418

Group type: EXPERIMENTAL
Intervention: Crystal music intervention
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard intervention (control)
Number of subjects: 70
Study: 24622155

Group type: EXPERIMENTAL
Intervention: Functional Balance Training (FBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Education alone
Number of subjects: 0
Study: 22159695

Group type: EXPERIMENTAL
Intervention: Anorectal biofeedback (AB)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Biofeedback control (BC)
Number of subjects: 21
Study: 20214062

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment with alternative use of two groups of acupoints and electroacupuncture in disperse-dense wave for 30 min
Number of subjects: 63
Study: 17068074

Group type: EXPERIMENTAL
Intervention: Home visiting intervention
Number of subjects: 131

Group type: COMPARATOR
Intervention: Standard services (Control)
Number of subjects: 131
Study: 15361516

Group type: EXPERIMENTAL
Intervention: Low glycogen training protocol
Number of subjects: 7

Group type: COMPARATOR
Intervention: High glycogen training protocol
Number of subjects: 7
Study: 12201386

Group type: EXPERIMENTAL
Intervention: VLT play (90 min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control activity (viewing a movie)
Number of subjects: 30
Study: 10774129

Group type: EXPERIMENTAL
Intervention: High-quality synthesized speech (DECtalk Express)
Number of subjects: 193

Group type: EXPERIMENTAL
Intervention: Low-quality synthesized speech (Monologue)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Human voice (control)
Number of subjects: 193
Study: 7745071

Group type: EXPERIMENTAL
Intervention: 100 micrograms gonadotrophin‐releasing hormone (GnRH)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 500 micrograms GnRH agonist (GnRHa)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 10,000 IU human chorionic gonadotrophin (HCG)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 500 micrograms GnRH
Number of subjects: 38
Study: 2032746

Group type: EXPERIMENTAL
Intervention: Paired filtration dialysis (PFD) 3x3 h/wk with 0.4 m2 polysulphone (PS) and 1.36 m2 cuprophan (CU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Paired filtration dialysis (PFD) 3x4 h/wk with 0.4 m2 polysulphone (PS) and 1.06 m2 cuprophan (CU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional hemodialysis (HD) 3x4 h/wk with 1.36 m2 cuprophan (CU)
Number of subjects: 0
Study: 6118058

Group type: EXPERIMENTAL
Intervention: PGE‐2 aerosol in alcohol solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo of ethyl alcohol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Isoproterenol and ethyl alcohol aerosol
Number of subjects: 50
Study: 31701485

Group type: EXPERIMENTAL
Intervention: Cladribine tablets
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30838781

Group type: EXPERIMENTAL
Intervention: iPex II
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Root ZX
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Apex ID
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (Intraoral periapical radiograph)
Number of subjects: 60
Study: 27889332

Group type: EXPERIMENTAL
Intervention: Aerobic exercise intervention (two 30‐min sessions per week for 4 months)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Reference group (lectures)
Number of subjects: 116
Study: 25526757

Group type: EXPERIMENTAL
Intervention: Intravaginal metronidazole 750 mg plus miconazole 200 mg
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 24561148

Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 1299

Group type: COMPARATOR
Intervention: Clopidogrel
Number of subjects: 1299
Study: 22446438

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Meloxicam
Number of subjects: 25
Study: 21046988

Group type: EXPERIMENTAL
Intervention: Livina (2 capsules twice daily) with ATT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo with ATT
Number of subjects: 0
Study: 17987463

Group type: EXPERIMENTAL
Intervention: Diluted diesel exhaust (DE) inhalation (200 microg/m(3) of fine particulate matter)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Filtered air (FA) exposure
Number of subjects: 5
Study: 15955903

Group type: EXPERIMENTAL
Intervention: Thalidomide (269 patients)
Number of subjects: 553

Group type: COMPARATOR
Intervention: No thalidomide (284 patients)
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Cumulative dexamethasone dose
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 553

Group type: EXPERIMENTAL
Intervention: Younger age
Number of subjects: 553
Study: 12078468

Group type: EXPERIMENTAL
Intervention: Experimental group listened to a word list and short story selection.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group listened to tapes of white noise.
Number of subjects: 0
Study: 9860145

Group type: EXPERIMENTAL
Intervention: Felodipine infusion
Number of subjects: 16
Study: 7719388

Group type: EXPERIMENTAL
Intervention: Minnesota Heart Health Program (MHHP) community intervention activities including risk factor screening, mass media education, adult education classes, worksite interventions, home correspondence programs, school‐based programs, restaurant programs, and point‐of‐purchase education in supermarkets.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (matched communities without the MHHP intervention)
Number of subjects: 0
Study: 2223582

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TM), 30 mg per day for 2 years
Number of subjects: 308

Group type: COMPARATOR
Intervention: No therapy
Number of subjects: 308

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TM)
Number of subjects: 308
Study: 7368968

Group type: EXPERIMENTAL
Intervention: Subcutaneous heparin, 5 000 IU twice daily
Number of subjects: 99

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 99
Study: 30411542

Group type: EXPERIMENTAL
Intervention: Intensive education format (13.5 h over two consecutive days)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-intensive education format (sequential 90-min tutorials delivered 1 week apart)
Number of subjects: 48
Study: 28425827

Group type: EXPERIMENTAL
Intervention: SRP + glycine powder air-polishing (GPAP)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 60
Study: 25874236

Group type: EXPERIMENTAL
Intervention: Metformin treatment
Number of subjects: 206

Group type: COMPARATOR
Intervention: Insulin treatment
Number of subjects: 206
Study: 23338656

Group type: EXPERIMENTAL
Intervention: Obstacle crossing training
Number of subjects: 20

Group type: COMPARATOR
Intervention: Overground walking training
Number of subjects: 20
Study: 17326161

Group type: EXPERIMENTAL
Intervention: Sertraline (75-100 mg/day)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 15016017

Group type: EXPERIMENTAL
Intervention: Same-day full-mouth scaling and root planing (FM-SRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Quadrant scaling and root planing (Q-SRP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both FM-SRP and Q-SRP
Number of subjects: 40
Study: 11035676

Group type: EXPERIMENTAL
Intervention: Formoterol (FM), 12 microg, for 2 weeks and FM, 24 microg, for 2 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Budesonide (BUD), 400 microg, for 2 weeks and BUD, 800 microg, for 2 weeks
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: FM, 12 microg, plus BUD, 400 microg, for 2 weeks and FM, 24 microg, plus BUD, 800 microg, for 2 weeks
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination therapy (FM plus BUD)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All three treatments (FM, BUD, FM plus BUD)
Number of subjects: 15
Study: 8736460

Group type: EXPERIMENTAL
Intervention: Pinacidil (25 mg, orally)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1302543

Group type: EXPERIMENTAL
Intervention: Cang Dou Pill
Number of subjects: 648

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 648
Study: 3927691

Group type: EXPERIMENTAL
Intervention: Nicardipine (average daily dosage 89 mg, range 40 to 160)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 17
Study: 31631215

Group type: EXPERIMENTAL
Intervention: Opioid substitution treatment (OST)
Number of subjects: 2466
Study: 31655598

Group type: EXPERIMENTAL
Intervention: OSCAR intervention (monthly structured interviews by Social Care Nurses)
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group (no structured interviews)
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: OSCAR intervention
Number of subjects: 350

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 350
Study: 29292259

Group type: EXPERIMENTAL
Intervention: Face mask ventilation with 100% oxygen (Group 1, FiO2=1)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Face mask ventilation with air (Group 2, FiO2=0.21)
Number of subjects: 80
Study: 25883112

Group type: EXPERIMENTAL
Intervention: Insulin
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 32

Group type: COMPARATOR
Intervention: Saline Control
Number of subjects: 32
Study: 23673377

Group type: EXPERIMENTAL
Intervention: Self-rated health (RS)
Number of subjects: 465

Group type: EXPERIMENTAL
Intervention: Self-rated health (RS) after adjustment
Number of subjects: 465
Study: 21823911

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Aripiprazole 30 mg/day
Number of subjects: 296

Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day and 30 mg/day pooled
Number of subjects: 296

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 296
Study: 18521090

Group type: EXPERIMENTAL
Intervention: Iloperidone
Number of subjects: 407
Study: 16719877

Group type: EXPERIMENTAL
Intervention: Midazolam (0.5 mg x kg(‐1)) with diphenhydramine (1.25 mg x kg(‐1))
Number of subjects: 96

Group type: COMPARATOR
Intervention: Midazolam (0.5 mg x kg(‐1)) alone
Number of subjects: 96
Study: 15553109

Group type: EXPERIMENTAL
Intervention: Single oral dose of 3 mg phenprocoumon
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Pool plasma analysis
Number of subjects: 62
Study: 11219143

Group type: EXPERIMENTAL
Intervention: Sodium Phosphate (FS)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Polyethylene Glycol (PEG)
Number of subjects: 100
Study: 9489149

Group type: EXPERIMENTAL
Intervention: Reabsorbable microparticulate substance (Gelfoam)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Non reabsorbable microparticulate substances (Ivalon, ITC contour, Terbal)
Number of subjects: 13
Study: 8437318

Group type: EXPERIMENTAL
Intervention: Portal nutrition (10 patients)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Systemic nutrition (10 patients)
Number of subjects: 20
Study: 2875954

Group type: EXPERIMENTAL
Intervention: Labetalol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oxprenolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Metoprolol
Number of subjects: 0
Study: 28972854

Group type: EXPERIMENTAL
Intervention: 500 mL of milk (MILK)
Number of subjects: 10

Group type: COMPARATOR
Intervention: 500 mL of carbohydrate drink (CHO)
Number of subjects: 10
Study: 26315481

Group type: EXPERIMENTAL
Intervention: Corticosteroid combined with oral tacrolimus (TAC, target trough blood concentration of 4‐8 ng/mL)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Intravenous cyclophosphamide (CYC, 750 mg/m(2)/mo)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Oral mycophenolate mofetil (MMF, 1.5‐2.0 g/d)
Number of subjects: 90
Study: 24887223

Group type: COMPARATOR
Intervention: S100A12 levels in TRALI patients
Number of subjects: 46

Group type: COMPARATOR
Intervention: HMGB1 expression and levels of sRAGE in TRALI patients
Number of subjects: 46

Group type: COMPARATOR
Intervention: No specific intervention reported
Number of subjects: 46
Study: 22354163

Group type: EXPERIMENTAL
Intervention: Methadone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Buprenorphine
Number of subjects: 0
Study: 20644160

Group type: EXPERIMENTAL
Intervention: BCG vaccination at birth
Number of subjects: 0

Group type: COMPARATOR
Intervention: Delayed BCG vaccination at 4 1/2 months
Number of subjects: 0
Study: 18387999

Group type: EXPERIMENTAL
Intervention: Proficiency-based laparoscopic simulator training
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 15
Study: 16205453

Group type: EXPERIMENTAL
Intervention: Sildenafil
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12683845

Group type: EXPERIMENTAL
Intervention: Temperature modulation between 38 and 22 degrees C for multiple cycles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Temperature modulation conditions
Number of subjects: 0
Study: 10575809

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Halothane
Number of subjects: 40
Study: 9138754

Group type: EXPERIMENTAL
Intervention: AIDS cases
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Alzheimer's cases
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: HIV-positive asymptomatic cases
Number of subjects: 23

Group type: COMPARATOR
Intervention: Seronegative asymptomatic cases
Number of subjects: 23

Group type: COMPARATOR
Intervention: Non-infected control cultures
Number of subjects: 23
Study: 1677320

Group type: EXPERIMENTAL
Intervention: 15 mg MK-467
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 30 mg MK-467
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6869349

Group type: EXPERIMENTAL
Intervention: Metoclopramide 10 mg orally before meals and at bedtime
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional endoscopic treatment (mechanical fragmentation and instillation of papain solution)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Long-term metoclopramide treatment
Number of subjects: 24
Study: 31873985

Group type: EXPERIMENTAL
Intervention: Febuxostat (10‐40 mg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Allopurinol (100‐200 mg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Febuxostat
Number of subjects: 64

Group type: COMPARATOR
Intervention: Allopurinol
Number of subjects: 64